{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:24:18Z","timestamp":1784672658380,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Foundation for Young Scientists of China","award":["8150020951"],"award-info":[{"award-number":["8150020951"]}]},{"name":"Natural Science Foundation for Young Scientists of Hunan Province","award":["2016JJ4099"],"award-info":[{"award-number":["2016JJ4099"]}]},{"name":"the Scientific research plan of the Hunan Provincial Health Commission","award":["202204022475"],"award-info":[{"award-number":["202204022475"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"DOI":"10.1186\/s12864-025-11323-4","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:49:12Z","timestamp":1739821752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Whole exome sequence reveals genetic profiles of primary cardiomyopathy and genotype-phenotype association in Chinese population"],"prefix":"10.1186","volume":"26","author":[{"given":"Rui-lin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"6","key":"11323_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368\u201378.","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"11323_CR2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCRESAHA.119.315268","volume":"124","author":"JT Willerson","year":"2019","unstructured":"Willerson JT. The Medical and device-related treatment of heart failure. Circ Res. 2019;124(11):1519.","journal-title":"Circ Res"},{"key":"11323_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev-med-042220-021539","volume":"73","author":"BJ Maron","year":"2022","unstructured":"Maron BJ, Rowin EJ, Maron MS. Hypertrophic cardiomyopathy: New concepts and therapies. Annu Rev Med. 2022;73:363\u201375.","journal-title":"Annu Rev Med"},{"issue":"2","key":"11323_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1715","volume":"22","author":"CV Tuohy","year":"2020","unstructured":"Tuohy CV, Kaul S, Song HK, Nazer B, Heitner SB. Hypertrophic cardiomyopathy: the future of treatment. Eur J Heart Fail. 2020;22(2):228\u201340.","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"11323_CR5","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra0902923","volume":"364","author":"H Watkins","year":"2011","unstructured":"Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopathies. N Engl J Med. 2011;364(17):1643\u201356.","journal-title":"N Engl J Med"},{"issue":"23","key":"11323_CR6","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1136\/heartjnl-2021-320424","volume":"108","author":"TF Spracklen","year":"2022","unstructured":"Spracklen TF, Keavney B, Laing N, Ntusi N, Shaboodien G. Modern genomic techniques in the identification of genetic causes of cardiomyopathy. Heart. 2022;108(23):1843\u201350.","journal-title":"Heart"},{"issue":"10092","key":"11323_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390(10092):400\u201314.","journal-title":"Lancet"},{"issue":"9862","key":"11323_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381(9862):242\u201355.","journal-title":"Lancet"},{"issue":"1","key":"11323_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12920-022-01388-5","volume":"15","author":"S Ghasemi","year":"2022","unstructured":"Ghasemi S, Mahdavi M, Maleki M, Salahshourifar I, Kalayinia S. A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole\u2013exome sequencing. BMC Med Genomics. 2022;15(1):234.","journal-title":"BMC Med Genomics"},{"key":"11323_CR10","doi-asserted-by":"crossref","unstructured":"Orlova A, Guseva D, Ryzhkova O. Identification of a Novel De Novo variant in the CASZ1 causing a rare type of dilated cardiomyopathy. Int J Mol Sci 2022, 23(20).","DOI":"10.3390\/ijms232012506"},{"issue":"1","key":"11323_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jmedgenet-2019-106330","volume":"57","author":"R Almomani","year":"2020","unstructured":"Almomani R, Herkert JC, Posafalvi A, Post JG, Boven LG, van der Zwaag PA, Willems P, van Veen-Hof IH, Verhagen JMA, Wessels MW, et al. Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy. J Med Genet. 2020;57(1):23\u201330.","journal-title":"J Med Genet"},{"issue":"9","key":"11323_CR12","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ejhf.144","volume":"16","author":"J Wang","year":"2014","unstructured":"Wang J, Wang Y, Zou Y, Sun K, Wang Z, Ding H, Yuan J, Wei W, Hou Q, Wang H, et al. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy. Eur J Heart Fail. 2014;16(9):950\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"11323_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ejheart.2006.10.019","volume":"9","author":"H Gullu","year":"2007","unstructured":"Gullu H, Erdogan D, Caliskan M, Tok D, Kulaksizoglu S, Yildirir A, Muderrisoglu H. Elevated serum uric acid levels impair coronary microvascular function in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2007;9(5):466\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"11323_CR14","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1681\/ASN.2014070660","volume":"26","author":"ME Kleber","year":"2015","unstructured":"Kleber ME, Delgado G, Grammer TB, Silbernagel G, Huang J, Kramer BK, Ritz E, Marz W. Uric Acid and Cardiovascular events: a mendelian randomization study. J Am Soc Nephrol. 2015;26(11):2831\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"11323_CR15","doi-asserted-by":"publisher","first-page":"e1002937","DOI":"10.1371\/journal.pmed.1002937","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Meng X, He Y, Spiliopoulou A, Timofeeva M, Wei WQ, Gifford A, Yang T, Varley T, Tzoulaki I, et al. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: a phenome-wide mendelian randomization study. PLoS Med. 2019;16(10):e1002937.","journal-title":"PLoS Med"},{"issue":"23","key":"11323_CR16","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, Duboc D, Gimeno J, de Groote P, Imazio M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850\u20138.","journal-title":"Eur Heart J"},{"issue":"10316","key":"11323_CR17","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/S0140-6736(21)01205-8","volume":"398","author":"SR Ommen","year":"2021","unstructured":"Ommen SR, Semsarian C. Hypertrophic cardiomyopathy: a practical approach to guideline directed management. Lancet. 2021;398(10316):2102\u20138.","journal-title":"Lancet"},{"issue":"9","key":"11323_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","volume":"20","author":"RE Hershberger","year":"2018","unstructured":"Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, Morales A, Taylor MRG, Vatta M, Ware SM, et al. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20(9):899\u2013909.","journal-title":"Genet Med"},{"issue":"14","key":"11323_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","volume":"55","author":"F Girolami","year":"2010","unstructured":"Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, Baldini K, Torricelli F, Yeates L, Cecchi F, Ackerman MJ, et al. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol. 2010;55(14):1444\u201353.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"11323_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s12265-023-10403-8","volume":"16","author":"E Nagyova","year":"2023","unstructured":"Nagyova E, Hoorntje ET, Te Rijdt WP, Bosman LP, Syrris P, Protonotarios A, Elliott PM, Tsatsopoulou A, Mestroni L, Taylor MRG, et al. A systematic analysis of the clinical Outcome Associated with multiple reclassified desmosomal gene variants in Arrhythmogenic Right Ventricular Cardiomyopathy patients. J Cardiovasc Transl Res. 2023;16(6):1276\u201386.","journal-title":"J Cardiovasc Transl Res"},{"issue":"9","key":"11323_CR21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.ajhg.2023.08.003","volume":"110","author":"KA McGurk","year":"2023","unstructured":"McGurk KA, Zhang X, Theotokis P, Thomson K, Harper A, Buchan RJ, Mazaika E, Ormondroyd E, Wright WT, Macaya D, et al. The penetrance of rare variants in cardiomyopathy-associated genes: a cross-sectional approach to estimating penetrance for secondary findings. Am J Hum Genet. 2023;110(9):1482\u201395.","journal-title":"Am J Hum Genet"},{"issue":"10","key":"11323_CR22","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","volume":"128","author":"AJ Marian","year":"2021","unstructured":"Marian AJ. Molecular genetic basis of hypertrophic cardiomyopathy. Circ Res. 2021;128(10):1533\u201353.","journal-title":"Circ Res"},{"issue":"1","key":"11323_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290146","volume":"13","author":"MW Chung","year":"2003","unstructured":"Chung MW, Tsoutsman T, Semsarian C. Hypertrophic cardiomyopathy: from gene defect to clinical disease. Cell Res. 2003;13(1):9\u201320.","journal-title":"Cell Res"},{"issue":"1","key":"11323_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","volume":"144","author":"E Jordan","year":"2021","unstructured":"Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, Celeghin R, Edwards M, Fan J, Ingles J, et al. Evidence-based Assessment of genes in dilated cardiomyopathy. Circulation. 2021;144(1):7\u201319.","journal-title":"Circulation"},{"key":"11323_CR25","doi-asserted-by":"publisher","first-page":"1118585","DOI":"10.3389\/fmed.2023.1118585","volume":"10","author":"E Martinez-Barrios","year":"2023","unstructured":"Martinez-Barrios E, Grassi S, Brion M, Toro R, Cesar S, Cruzalegui J, Coll M, Alcalde M, Brugada R, Greco A, et al. Molecular autopsy: twenty years of post-mortem diagnosis in sudden cardiac death. Front Med (Lausanne). 2023;10:1118585.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"11323_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11427-020-1951-4","volume":"65","author":"L Xiao","year":"2022","unstructured":"Xiao L, Wu D, Sun Y, Hu D, Dai J, Chen Y, Wang D. Whole-exome sequencing reveals genetic risks of early-onset sporadic dilated cardiomyopathy in the Chinese Han population. Sci China Life Sci. 2022;65(4):770\u201380.","journal-title":"Sci China Life Sci"},{"issue":"23","key":"11323_CR27","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","volume":"138","author":"N Ma","year":"2018","unstructured":"Ma N, Zhang JZ, Itzhaki I, Zhang SL, Chen H, Haddad F, Kitani T, Wilson KD, Tian L, Shrestha R, et al. Determining the pathogenicity of a genomic variant of Uncertain significance using CRISPR\/Cas9 and Human-Induced pluripotent stem cells. Circulation. 2018;138(23):2666\u201381.","journal-title":"Circulation"},{"key":"11323_CR28","doi-asserted-by":"publisher","first-page":"843837","DOI":"10.3389\/fcvm.2022.843837","volume":"9","author":"T Xie","year":"2022","unstructured":"Xie T, Yang Y, Gong K, Luo Y, Guo H, Liu R, Wang L, Tan Z, Luo J, Xie L. Whole-exome sequencing identifies a novel variant (c.1538T\u2009>\u2009C) of TNNI3K in Arrhythmogenic Right Ventricular Cardiomyopathy. Front Cardiovasc Med. 2022;9:843837.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"11323_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, Mazzarotto F, Blair E, Seller A, Taylor JC, et al. Reassessment of mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19(2):192\u2013203.","journal-title":"Genet Med"},{"issue":"12","key":"11323_CR30","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1053\/euhj.1998.1188","volume":"19","author":"F Leyva","year":"1998","unstructured":"Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, Poole-Wilson PA, Coats AJ. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J. 1998;19(12):1814\u201322.","journal-title":"Eur Heart J"},{"issue":"5","key":"11323_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.hrtlng.2017.06.004","volume":"46","author":"I Sagy","year":"2017","unstructured":"Sagy I, Salman AA, Kezerle L, Erez O, Yoel I, Barski L. Peripartum cardiomyopathy is associated with increased uric acid concentrations: a population based study. Heart Lung. 2017;46(5):369\u201374.","journal-title":"Heart Lung"},{"issue":"6","key":"11323_CR32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1067\/mhj.2002.122122","volume":"143","author":"M Cicoira","year":"2002","unstructured":"Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Zeni P, Zardini P. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J. 2002;143(6):1107\u201311.","journal-title":"Am Heart J"},{"issue":"12","key":"11323_CR33","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.21037\/tp-21-537","volume":"10","author":"TT Li","year":"2021","unstructured":"Li TT, Li HY, Cheng J. Changes of serum uric acid and its clinical correlation in children with dilated cardiomyopathy. Transl Pediatr. 2021;10(12):3211\u20137.","journal-title":"Transl Pediatr"},{"issue":"4","key":"11323_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1751-7133.2010.00144.x","volume":"16","author":"H Kim","year":"2010","unstructured":"Kim H, Shin HW, Son J, Yoon HJ, Park HS, Cho YK, Han CD, Nam CW, Hur SH, Kim YN, et al. Uric acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level. Congest Heart Fail. 2010;16(4):153\u20138.","journal-title":"Congest Heart Fail"},{"issue":"11","key":"11323_CR35","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1002\/ejhf.1984","volume":"22","author":"S Selvaraj","year":"2020","unstructured":"Selvaraj S, Claggett BL, Pfeffer MA, Desai AS, Mc Causland FR, McGrath MM, Anand IS, van Veldhuisen DJ, Kober L, Janssens S, et al. Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. Eur J Heart Fail. 2020;22(11):2093\u2013101.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"11323_CR36","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ejhf.2433","volume":"24","author":"K McDowell","year":"2022","unstructured":"McDowell K, Welsh P, Docherty KF, Morrow DA, Jhund PS, de Boer RA, O\u2019Meara E, Inzucchi SE, Kober L, Kosiborod MN, et al. Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF. Eur J Heart Fail. 2022;24(6):1066\u201376.","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"11323_CR37","doi-asserted-by":"publisher","first-page":"e026301","DOI":"10.1161\/JAHA.122.026301","volume":"11","author":"M Nishino","year":"2022","unstructured":"Nishino M, Egami Y, Kawanami S, Sugae H, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, et al. Lowering Uric Acid May improve prognosis in patients with hyperuricemia and heart failure with preserved ejection fraction. J Am Heart Assoc. 2022;11(19):e026301.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"11323_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.120.16547","volume":"77","author":"D Gill","year":"2021","unstructured":"Gill D, Cameron AC, Burgess S, Li X, Doherty DJ, Karhunen V, Abdul-Rahim AH, Taylor-Rowan M, Zuber V, Tsao PS, et al. Urate, blood pressure, and Cardiovascular Disease: evidence from mendelian randomization and Meta-analysis of clinical trials. Hypertension. 2021;77(2):383\u201392.","journal-title":"Hypertension"},{"key":"11323_CR39","doi-asserted-by":"publisher","first-page":"f4262","DOI":"10.1136\/bmj.f4262","volume":"347","author":"TM Palmer","year":"2013","unstructured":"Palmer TM, Nordestgaard BG, Benn M, Tybjaerg-Hansen A, Davey Smith G, Lawlor DA, Timpson NJ. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ. 2013;347:f4262.","journal-title":"BMJ"},{"issue":"4","key":"11323_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jacc.2015.10.086","volume":"67","author":"T Keenan","year":"2016","unstructured":"Keenan T, Zhao W, Rasheed A, Ho WK, Malik R, Felix JF, Young R, Shah N, Samuel M, Sheikh N, et al. Causal Assessment of Serum Urate Levels in Cardiometabolic diseases through a mendelian randomization study. J Am Coll Cardiol. 2016;67(4):407\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"11323_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1073\/pnas.022641799","volume":"99","author":"T Kawada","year":"2002","unstructured":"Kawada T, Nakazawa M, Nakauchi S, Yamazaki K, Shimamoto R, Urabe M, Nakata J, Hemmi C, Masui F, Nakajima T, et al. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters. Proc Natl Acad Sci U S A. 2002;99(2):901\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"11323_CR42","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1161\/01.CIR.0000089371.11664.27","volume":"108","author":"Y Yue","year":"2003","unstructured":"Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation. 2003;108(13):1626\u201332.","journal-title":"Circulation"},{"issue":"5","key":"11323_CR43","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nm.3510","volume":"20","author":"M Perdomini","year":"2014","unstructured":"Perdomini M, Belbellaa B, Monassier L, Reutenauer L, Messaddeq N, Cartier N, Crystal RG, Aubourg P, Puccio H. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich\u2019s ataxia. Nat Med. 2014;20(5):542\u20137.","journal-title":"Nat Med"},{"issue":"8","key":"11323_CR44","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","volume":"126","author":"S Wang","year":"2020","unstructured":"Wang S, Li Y, Xu Y, Ma Q, Lin Z, Schlame M, Bezzerides VJ, Strathdee D, Pu WT. AAV Gene Therapy prevents and reverses heart failure in a murine knockout model of Barth Syndrome. Circ Res. 2020;126(8):1024\u201339.","journal-title":"Circ Res"},{"key":"11323_CR45","doi-asserted-by":"crossref","unstructured":"Eijgenraam TR, Stege NM, Oliveira Nunes Teixeira V, de Brouwer R, Schouten EM, Grote Beverborg N, Sun L, Spater D, Knoll R, Hansson KM et al. Antisense therapy attenuates Phospholamban p.(Arg14del) cardiomyopathy in mice and reverses protein aggregation. Int J Mol Sci 2022, 23(5).","DOI":"10.3390\/ijms23052427"},{"issue":"10","key":"11323_CR46","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/CIRCRESAHA.120.315855","volume":"126","author":"A Cannata","year":"2020","unstructured":"Cannata A, Ali H, Sinagra G, Giacca M. Gene Therapy for the Heart lessons learned and future perspectives. Circ Res. 2020;126(10):1394\u2013414.","journal-title":"Circ Res"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-11323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-025-11323-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-11323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:51:25Z","timestamp":1739821885000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-025-11323-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11323"],"URL":"https:\/\/doi.org\/10.1186\/s12864-025-11323-4","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"18 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was implemented in accordance with the principle of the Declaration of Helsinki and approved by the Ethics Committee of the Second Xiangya Hospital of Central South University. Written informed consents were obtained from all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}